P360All tools
483 Signal · For pharma / CDMO QA

12 hours,
with severity.

FDA Form 483 observations and Warning Letters, parsed within 12 hours of publication, with per-inspector severity scoring and repeat-finding flags. Built on the openFDA + FOIA pipeline, delivered to your inbox, Slack, or API.

Built on public sources. Informational, not compliance or legal advice.

12-hour parse

New 483s and Warning Letters are read and structured within 12 hours of publication.

Severity scoring

Per-inspector severity scores and flags for repeat findings across sites.

Your channel

Delivered by newsletter, Slack, or API — fitted to how your QA team already works.

How it works

  1. 01We watch the public record.openFDA plus FOIA-sourced 483s and Warning Letters, monitored continuously.
  2. 02We parse and score.Each document is structured, scored for severity by inspector, and checked for repeat findings.
  3. 03You get the signal.Within 12 hours, in your inbox, Slack, or via API — with the context your QA team needs.

Pricing

Start here
Free weekly trends

A free weekly newsletter of the week's notable 483s and Warning Letters, with trends.

Pro feed
Real-time, Slack / API

12-hour alerts with severity and repeat-finding flags, filtered to your sites, products, and inspectors. Pricing shared on request.

FAQ

Where does the data come from?

Publicly available FDA records via openFDA and FOIA. We structure and score them; we don't have non-public access.

Is this compliance or legal advice?

No. 483 Signal is informational. It helps your team see and prioritize what's published; it doesn't tell you what to do about your own compliance — that's your QA and counsel.

How accurate is the severity score?

It's our analytical estimate based on the document text and history. We're transparent about how it's derived; underlying government data can change or be corrected.

Can I filter to my own sites and suppliers?

Yes, on the pro feed — filtered by site, product, supplier, or inspector.

Get the free weekly newsletter

The week's notable 483s and Warning Letters, with trends. Unsubscribe anytime.